Increased BDNF levels in long-term bipolar disorder patients

Braz J Psychiatry. 2013 Mar;35(1):67-9. doi: 10.1016/j.rbp.2012.05.011.

Abstract

Introduction: Bipolar disorder (BD) is a prevalent, chronic and progressive illness. There is a growing body of evidence indicating that brain-derived neurotrophic factor (BDNF) plays an important role in the pathophysiology of BD.

Objective: The aim of this study was to evaluate BDNF plasma levels in BD patients with long term illness in comparison with controls.

Methods: 87 BD type I patients and 58 controls matched by age, gender and education level were enrolled in this study. All subjects were assessed by the Mini-International Neuropsychiatric Interview and the patients by the Young Mania Rating Scale and the Hamilton Depression Rating Scale. The plasma levels of BDNF were measured by ELISA.

Results: On average, patients had suffered from BD for 23.4 years. In comparison with controls, BD patients with mania presented a 1.90-fold increase in BDNF plasma levels (p = .001), while BD patients in remission presented a 1.64-fold increase in BDNF plasma levels (p = .03). BDNF plasma levels were not influenced by age, length of illness or current medications.

Conclusions: The present study suggests that long-term BD patients exhibit increased circulating levels of BDNF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Biomarkers / blood
  • Bipolar Disorder / blood*
  • Bipolar Disorder / physiopathology
  • Brain-Derived Neurotrophic Factor / blood*
  • Case-Control Studies
  • Cross-Sectional Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Time Factors

Substances

  • Biomarkers
  • Brain-Derived Neurotrophic Factor